EnzyQuest Receives ISO 13485 Certification
EnzyQuest, a biotech start-up, focused on molecular biology products and related reagents across applications in academic and industrial research, has been granted ISO 13485:2016 certification for the design, development, manufacturing and distribution of molecular biology products for the development of in-vitro diagnostic devices.
“The National Quality Assessment Center of Technology in Health successfully audited EnzyQuest’s Quality Management System and issued the ISO 13485:2016 to EnzyQuest along with ISO 9001:2015 and DY8/1348:2004, thus leveraging our quality systems to meet and exceed the expectations of our customers.”, states Dimitris Koutsioulis, C.E.O. of EnzyQuest.
To read the full press release press here
For specific certification information visit EnzyQuest’s certifications page
EnzyQuest, member of a consortium awarded with €2.4M EU funding (H2020)
We are excited to announce that an eight-partner consortium (IRIS-COV), of which we are members, has been awarded an EU funding of €2.4 M (H2020-SCI-PHE-CORONAVIRUS-2020-2). The “IRIS-COV” project is one of the 23 to receive funding from a total of 454 submitted proposals.
The aim of the project is the market release of a portable device to carry out a combined test for SARS-CoV-2 and Influenza A at the point-of-care (POC). EnzyQuest is actively engaged in manufacturing and large-scale production of reagent-kits. In addition to EnzyQuest, the consortium includes BIOPIX-T (Crete, Greece) which is the medical device designer, manufacturer and provider, IMBB-FORTH (Crete, Greece) which will coordinate the project, three hospitals in Europe (UCLH-UK, INSERM-France and ULB-Belgium) which will perform the clinical validations, one consulting company for the certification (PKNM-Switzerland) and an end-user in South Africa (Kiara Health).
The first Greek diagnostic tests for Coronavirus
[Greek] EnzyQuest: A 400.000 euro funding & the first Greek diagnostic tests for Coronavirus [link]
(Source: fortunegreece.com)
Greek startup is creating a coronavirus diagnostic test.
[Greek] Greek startup is creating coronavirus diagnostic test. Tests by biotech company EnzyQuest in final stage
(Source: naftemporiki.gr)